Ozempic and Rybelsus are approved for type 2 diabetes
Sodiumglucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) both improve cardiovascular outcomes, but their comparative roles in HF and the potential value of combination therapy remain uncertain
No matter what, protect your muscles
"Both are notorious for causing gastrointestinal issues," says John Aurora, endocrinology clinical pharmacy specialist at Tufts Medical Center in Boston
This method is common for peptides because they are often broken down by the digestive system if taken orally, making them ineffective
These medications work like natural hormones in your body, helping with insulin release, digestion, and appetite control